A single jab hailed as a ‘potential cure’ for type 1 diabetes will be trialled this year – raising hopes it could finally end the need for multiple daily insulin…
NEW YORK, Feb. 9, 2026 /PRNewswire/ — Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, is proud to announce Land O’Frost, a third-generation,…
Breakthrough T1DSpotlight on OPF-310: A porcine-derived cell therapy in clinical trialsOne of our most promising avenues toward cures for type 1 diabetes is cell therapies. Learn more about one of…
Breakthrough T1DCongress Passes Bipartisan Extension of the Special Diabetes Program, Securing Critical T1D Research FundingCongress has passed bipartisan legislation to extend and strengthen the Special Diabetes Program (SDP), a cornerstone…
Breakthrough T1D“Do good, feel good”: Alecia Wesner’s T1D clinical trial journeyAs a Participant Advisory Council member, Alecia Wesner shares her lived experience with type 1 diabetes and clinical trials..7 hours…
NEW YORK, Jan. 29, 2026 /PRNewswire/ — Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, is thrilled to recognize the generosity of Ford…
Grant will strengthen insurance and Medicaid navigation and continuity of care for adults living with T1D NEW YORK, Jan. 15, 2026 /PRNewswire/ — Breakthrough T1D, the leading global type 1…
A new study offers fresh hope for people living with type 2 diabetes and obesity. Researchers report progress toward a pill that lowers blood sugar and boosts fat burning without…
Apple Watch glucose monitoring has taken a significant step forward with recent developments that could reshape how millions manage their blood sugar levels. When the Apple Watch first launched back…
BUENOS AIRES, Dec. 4 (UPI) — Argentine scientists have identified a mechanism that allows pancreatic beta cells, which produce insulin, to become resistant to damage. The finding opens the door…